Alternatives to BiomX

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Microbiome technology platform for developing novel therapeutics.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.